Skip to main
  1. Stocks
  2. Waters
  3. Forecast
WAT

Waters (WAT) Stock Forecast & Price Target

Waters (WAT) Analyst Ratings

Based on 18 analyst ratings
Buy
Strong Buy 33%
Buy 39%
Hold 28%
Sell 0%
Strong Sell 0%

Bulls say

Waters is supported by a stronger fundamental profile as its core analytical instruments business reaccelerates, with 3Q organic revenue up 10%, instruments up 10%, chemistry up 12%, and services up 8%, while full-year constant-currency growth guidance was raised to 9.1%–9.7% from 7.0%–9.0%. Its positive outlook is reinforced by the early-2026 merger with Becton Dickinson’s life science and diagnostics business, which adds turnaround and synergy potential through pricing, localization, and cost savings, while expanding exposure to diagnostics and discovery-related tools. Management also has durable end-market tailwinds from pharma manufacturing, GLP-1 workflows, China recovery, and reshoring, alongside new growth vectors from AI, replacement cycles, and the MOBILion acquisition into a ~$2.2 billion proteomics market.

Bears say

Waters is facing a fundamentally weaker outlook because the BD acquisition adds structurally challenged Biosciences & Diagnostics businesses just as core analytical instruments growth faces tougher comps, raising the risk that organic sales momentum permanently slows. The transaction also increases operational complexity and absorbs management time, while roughly $4B of assumed debt on top of existing debt constrains capital allocation flexibility and leaves the balance sheet less able to respond to any disappointment. If integration hiccups, slower-than-expected end-market recovery, or underperformance in the acquired assets occur, multiple compression could follow from several directions at once, especially given the five-year bottom ~23x P/E reference.

Waters (WAT) has been analyzed by 18 analysts, with a consensus rating of Buy. 33% of analysts recommend a Strong Buy, 39% recommend Buy, 28% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Waters and is not a guaranteed prediction by Public.com or investment advice.

Waters (WAT) Analyst Forecast & Price Prediction

Get the latest Waters (WAT) stock forecast, including analyst ratings and price predictions, with real-time AI-powered fundamental data and custom analysis

Start investing in Waters (WAT)

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Waters (WAT) Forecast

Analysts have given Waters (WAT) a Buy based on their latest research and market trends.

According to 18 analysts, Waters (WAT) has a Buy consensus rating as of Nov 20, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $461.17, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $461.17, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Waters (WAT)


Waters (WAT) Analyst Forecast & Price Prediction

Get the latest Waters (WAT) stock forecast, including analyst ratings and price predictions, with real-time AI-powered fundamental data and custom analysis

Start investing in Waters (WAT)

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.
Uncover WAT stock data and trends